ALDIJANA SACIC: Open Payments
NPI 1740807825 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247,843 in 281 payments from 4 companies in 2025. Trend: 2023 $69,883 · 2024 $189,433 · 2025 $247,843
Speaker / faculty: $209,075Travel & lodging: $28,222Consulting: $5,438Food & beverage: $5,108
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 122 | $133,873 |
| Janssen Pharmaceuticals, Inc | 111 | $91,322 |
| Otsuka America Pharmaceutical, Inc. | 47 | $22,617 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
Products named: INGREZZA, INVEGA SUSTENNA, REXULTI, INVEGA, UZEDY.
Industry payments across MO — which companies pay providers there.
